InvestorsHub Logo
icon url

Euripides90

05/22/17 9:20 AM

#36823 RE: symphon1 #36822

Stool-Bacterial-Pathogens-Panel-under-evaluation-at-over-40-sites...ahead-of-anticipated-FDA-clearance --
THAT IS HUGE!

Press Release: Great Basin Scientific Reports First Quarter 2017 Results
2 hours 15 minutes ago - DJNF
Great Basin Scientific Reports First Quarter 2017 Results

Company continues to reduce operating expenses and cash burn

-- First quarter revenue increased 14% year-over-year

-- 30% reduction in first quarter total operating expenses compared to

fourth quarter


-- First quarter net income was $21.5 million; non-GAAP net loss improved

27% from the fourth quarter

-- Stool Bacterial Pathogens Panel under evaluation at over 40 customer

sites ahead of anticipated FDA clearance
icon url

BRoberts1982

05/22/17 9:26 AM

#36824 RE: symphon1 #36822

Loss from operations - $6,447,106

They lose MILLIONS EVERY Q.


This is a VERY BROKEN BUSINESS MODEL. And IS NOT changing.

Revenues $ 830,777
Cost of sales 1,980,076

Now where are they going to come up with that level of cash loss?
They will do EXACTLY what they have done in the past.